Compounds > edetic acid
Page last updated: 2024-08-17

edetic acid and psma-617

edetic acid has been researched along with psma-617 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Afshar-Oromieh, A; Benesova, M; Eder, M; Eisenhut, M; Giesel, FL; Haberkorn, U; Hetzheim, H; Holland-Letz, T; Kopka, K; Kratochwil, C; Kübler, W; Mier, W; Neels, OC1
Bal, C; Ballal, S; Yadav, MP1
Ebenhan, T; Hayeshi, R; Kalombo, L; Mandiwana, V; Zeevaart, JR1
Bartholomä, M; Derks, YHW; Ezziddin, S; Franssen, GM; Khreish, F; Maus, S; Nagarajah, J; Privé, BM; Rosar, F1
Hong, H; Kung, HF; Li, L; Wang, G; Zang, J; Zhu, L; Zhu, Z1

Other Studies

5 other study(ies) available for edetic acid and psma-617

ArticleYear
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:11

    Topics: Adult; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Kidney; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Salivary Glands; Theranostic Nanomedicine; Tissue Distribution

2015
Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC: A Proof-of-Principle Application.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:8

    Topics: Adult; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Oligopeptides; Organometallic Compounds; Organophosphorus Compounds; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals

2016
Preclinical Assessment Addressing Intravenous Administration of a [
    Molecules (Basel, Switzerland), 2021, Apr-30, Volume: 26, Issue:9

    Topics: Administration, Intravenous; Animals; Biomarkers; Chemical Phenomena; Dipeptides; Edetic Acid; Emulsions; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Male; Mice; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate-Specific Antigen; Radiopharmaceuticals; Tissue Distribution; Toxicity Tests, Acute; Zinc Isotopes

2021
89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
    Clinical nuclear medicine, 2022, May-01, Volume: 47, Issue:5

    Topics: Aged; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Zirconium

2022
Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer : A Pilot Study.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Pilot Projects; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms

2023